Medicine information RHESONATIV 625UI / ml solution for injection

Product code:
W52402002
Quantity:
1
Pack volume:
2ml
Indicated for:
immunosuppression
Route of administration:
injectable
Substance:
anti-D immunoglobulin (immunoglobulin)
ATC
J06BB01 — Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins
Anti-D immunoglobulin is a medication used to prevent Rh isoimmunization in Rh-negative women who have been exposed to Rh-positive blood, such as during pregnancy or childbirth. It contains antibodies that neutralize Rh-positive cells, thereby preventing the formation of antibodies against them.

The medication is administered via intramuscular or intravenous injection, according to the doctor's instructions. It is effective in preventing hemolytic complications in subsequent pregnancies.

Side effects may include pain at the injection site, fever, headache, and, in rare cases, severe allergic reactions. Close monitoring is essential during treatment.

Consult your doctor to discuss the benefits and risks of treatment with anti-D immunoglobulin. Follow the administration instructions to ensure therapy effectiveness.

General data about RHESONATIV 625UI / ml

Substance:
anti-D immunoglobulin
Date of latest medicines list:
01-06-2021
Product code:
W52402002
Strength:
625UI / ml
Pharmaceutical form:
solution for injection
Pack volume:
2ml
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
OCTAPHARMA AB - SUEDIA
Holder:
OCTAPHARMA (IP) SPRL - BELGIA
Shelf life:
30 months-after packaging for sale; after the first opening a fiolei-use immediately

Strengths available for anti-D immunoglobulin

  • 300mcg
  • 300mcg/2ml
  • 625UI/ml
  • 750UI/ml

Official documents

The correspondence between the document and the displayed text is unconfirmed.

Source institution
ANMDMR
Document language
Romanian

Warnings:

Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring

This medicine is subject to additional monitoring.